We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arix Bioscience Plc | LSE:ARIX | London | Ordinary Share | GB00BD045071 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 142.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMARIX
Arix Bioscience Plc
01 November 2017
Arix Bioscience to present at two investor conferences in November
LONDON, 1 November 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience") a global healthcare and life science company supporting medical innovation, will present at two investor conferences in November:
-- Stifel 2017 Healthcare Conference on November 15, 2017 at 11:40 a.m. ET at the Lotte New York Palace Hotel. Jonathan Peacock, Chairman, will make the presentation, and will participate in one-on-one investor meetings at the conference on 14 and 15 November.
-- Jefferies 2017 Global Healthcare Conference on 16 November, at 1:20 p.m. GMT at the Waldorf Hilton in London. Joe Anderson, CEO, will make the presentation and will participate in one-on-one investor meetings at the conference during the course of the day.
For both conferences, audio webcasts and the investor presentation will be available on Arix's website at https://arixbioscience.com/presentations on the days of the events. Webcast replays will be available following the live presentation.
For more information, please contact:
Arix Bioscience plc
Matthew Cole, Communications Director
+44 (0) 20 7290 1065
Consilium Strategic Communications
Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan
+44 (0)20 3709 5700
arix@consilium-comms.com
About Arix Bioscience plc
Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.
Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit www.arixbioscience.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABRBDGISXBGRB
(END) Dow Jones Newswires
November 01, 2017 03:00 ET (07:00 GMT)
1 Year Arix Bioscience Chart |
1 Month Arix Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions